Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile
Vinay Prasad MD MPH

@vprasadmdmph

Prof @ucsf, Physician-Scientist, IG @vprasadmdmph @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views mine

ID: 1194962714

linkhttps://www.youtube.com/@vprasadmdmph calendar_today18-02-2013 21:24:10

46,46K Tweet

291,291K Followers

4,4K Following

Jay Bhattacharya (@drjbhattacharya) 's Twitter Profile Photo

This excellent Florida program, approved by Ron DeSantis, supports nursing education and addresses the shortage of nurses. States around the country should consider it.

Ajin Abraham (@ajin_abraham) 's Twitter Profile Photo

So thoughtfully put. Many contenders on the ridiculous policy/recommendations front over the last few years, but what an egregious exhibit of ‘professing themselves to be wise, they became fools.’ Removing the perception of harm to cause actual harm.

So thoughtfully put. 

Many contenders on the ridiculous policy/recommendations front over the last few years, but what an egregious exhibit of ‘professing themselves to be wise, they became fools.’

Removing the perception of harm to cause actual harm.
Kevin S Shah, MD (@kevinshahmd) 's Twitter Profile Photo

Vinay Prasad MD MPH Traveling in-person for interviews (residency and fellowship) really pushed the applicant to showcase their interest because you had to (1) find coverage, (2) pay for hotel/travel, and (3) show up in person. It was not perfect, but it helped both sides in many ways.

Bryce Nickels (@bryce_nickels) 's Twitter Profile Photo

Prior to the emergence of COVID, Peter Hotez channeled NIH funds to reckless enhanced potential pandemic pathogens research in Wuhan. Astonishing he would be on a panel discussion of long COVID given his role in funding research that may have led to the emergence of the disease.

Prior to the emergence of COVID, Peter Hotez channeled NIH funds to reckless enhanced potential pandemic pathogens research in Wuhan. Astonishing he would be on a panel discussion of long COVID given his role in funding research that may have led to the emergence of the disease.
Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

Gottlieb should be disqualified from serving in any future administration. He's a sellout. He went from FDA director to Pfizer board. And he's a censor. Completely despicable behavior.

Alex Berenson (@alexberenson) 's Twitter Profile Photo

Tell us how you really feel, Vinay Prasad MD MPH! Don't hold back for once. (Seriously, though, I'm fascinated by how many people want to share dirt with me on Scotty Gotty. He is... oily, at best.)

Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

A typical mutiple myeloma doctor. 650,000 in personal fees taken BEYOND UNIVERSITY SALARY from all the pharma companies. Remember everyone needs a quadruplet and doublet maintenance ;)

A typical mutiple myeloma doctor.  650,000 in personal fees taken BEYOND UNIVERSITY SALARY from all the pharma companies.

Remember everyone needs a quadruplet and doublet maintenance ;)
Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

My op-ed in 2021 argued the opposite as Scott Gottlieb Gottlieb is everything wrong in politics. He worked as FDA director, then sold out to be Pfizer board. He pushed for vaccine mandates like a shill, and pushed twitter to censor Berenson.

My op-ed in 2021 argued the opposite as Scott Gottlieb
Gottlieb is everything wrong in politics.  He worked as FDA director, then sold out to be Pfizer board.  He pushed for vaccine mandates like a shill, and pushed twitter to censor Berenson.
Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

In today's Sensible Medicine Adam Cifu & I explain Elle Macpherson's decision to decline adjuvant chemo Decision was reasonable! Breast oncs are chasing 0.7% iDFS gains like lunatics! Holistic medicine did jack shit to help her EOD, she got lucky sensible-med.com/p/elle-macpher…

Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

Just a reminder. 5-year survival is a very bad metric to measure myeloma progress. In 2014 they changed the definition to include pre-clinical disease. That changes 5-year survival artificially. More opportunistic CBCs artificially change 5-year survival. There is progress, but

Just a reminder. 5-year survival is a very bad metric to measure myeloma progress. 
In 2014 they changed the definition to include pre-clinical disease. That changes 5-year survival artificially.  More opportunistic CBCs artificially change 5-year survival. There is progress, but